Andrea Costantino

@policlinico.mi.it

Gastroenterology and Endoscopy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Andrea Costantino


                  Download Compact PDF  
https://researchid.co/andreacostantino
M.D. Gastroenterologist at the Unit of Gastroenterology and Endoscopy of Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico

- Inflammatory bowel disease
- Celiac Disease
- Sonographer at "Centro di riferimento per l'ecografia gastroenterologica", I perform upper abdomen ultrasound, bowel ultrasound, Contrast Enhanced Ultrasound (CEUS), Shear Wave elastography, ultrasound guide for percutaneous biopsies, transanal ultrasounds.
- other interests: irritable bowel syndrome and functional disorders

EDUCATION

Medicine degree, cum laude (honours)
Specialty Board in Gastroenterology, cum laude (honours)
Università degli Studi di Palermo

Medical National Board, vote 270/270

2011: Doctor of Medicine, visiting at the Department of Hepatology of the Hospital Clínic of Barcelona
2010: Medical student, intern at the Unit of Hepatology of the Istituto mediterraneo per i trapianti e terapie ad alta
specializzazione/ University of Pittsburgh Medical Center (ISMETT/UPMC) of Palermo
2010: Medical student, intern at the Unity of Internal Medicine of Klinikum Rechts der Isar of the Technische Universität of
Munich, where I attended lessons, exams and courses
2009: Medical student, intern at the Unit of General and Transplantation Surgery of the Universitätsklinikum of Münster
2008: Medical student, intern at the Unit of Gastroenterology and Endoscopy of the Universitätsklinik of Innsbruck

English: C1
German: B1
French: B1

RESEARCH INTERESTS

Ultrasound
Pocket-Size Ultrasound
Hepatocellular Carcinoma
Inflammatory Bowel Disease
Celiac Disease
IBS
Telemedicine
58

Scopus Publications

3078

Scholar Citations

28

Scholar h-index

43

Scholar i10-index

Scopus Publications

  • Oral Immunotherapy-Induced Changes in IgE, IgG, and IgA: A Review of Antibody Isotype Shifts and Their Clinical Relevance in Food Allergy
    Giovanni Lasagni, Laura Vetrugno, Chiara Maria Maggiore, Chiara Galassetti, Giulia Di Colo, et al.
    Antibodies, 2026
    Background: Food allergy is a growing public health concern, and oral immunotherapy (OIT) has emerged as a promising approach to induce desensitization and potentially sustained unresponsiveness to allergenic foods. Changes in humoral immunity, particularly in allergen-specific immunoglobulin levels, play a central role in the immunological mechanisms underlying OIT. This review aims to summarize the current evidence on how OIT modulates allergen-specific immunoglobulin E (IgE), G (IgG) and A (IgA) responses in individuals with food allergy. Methods: We conducted a review of original research articles reporting longitudinal data on allergen-specific IgE, IgG, and/or IgA in patients undergoing OIT for common food allergens. Results: OIT was consistently associated with a transient increase in allergen-specific IgE levels during early phases, followed by a gradual decline. In contrast, Allergen-specific IgG4 levels showed a robust and sustained increase, correlating with desensitization and proposed to function as blocking antibodies. Several studies also reported an increase in allergen-specific IgA, particularly secretory IgA at mucosal sites, suggesting a potential role in enhancing mucosal tolerance and immune exclusion of allergens. Conclusions: Humoral immune responses during OIT are characterized by distinct and dynamic changes in immunoglobulin patterns. In particular, the rise in IgG4 and, in some cases, IgA suggests a role in promoting tolerance. Monitoring these biomarkers may offer insights into treatment efficacy and support individualized approaches to OIT.
  • Double-balloon enteroscopy evaluation and surveillance in patients with short bowel syndrome
    Lucia Scaramella, Andrea Sorge, Gian Eugenio Tontini, Elia Fracas, Veronica Smania, et al.
    Therapeutic Advances in Gastroenterology, 2026
    Background: Safety and usefulness of double-balloon enteroscopy (DBE) in patients with short bowel syndrome (SBS) are unknown. DBE could be effective in exploring the residual small bowel (SB) entirely, in monitoring patients receiving teduglutide (TED) treatment and, if necessary, could be operative. Objective: This study aimed to assess the safety, feasibility, and efficacy of enteroscopy in SBS patients. Design: Single center, retrospective. Methods: We collected data on patients with SBS patients undergoing DBE from December 2019 to October 2023. We analyzed the technical success total enteroscopy rates, adverse events, diagnostic yield, and residual SB length measurement. Results: A total of 12 SBS patients (8 females, median age at first enteroscopy, 66 years, interquartile range (IQR) 58–79) were included; among them, 10 received TED therapy (median interval from TED prescription to DBE surveillance 9.1 months (IQR 3.2–32.9)). Overall, 15 DBE procedures (3 retrograde) were performed, all of which were technically successful and completed without adverse events. The overall diagnostic yield was 60% for relevant findings, defined as conditions unknown before DBE. No SB malignancies were detected during the study period. In 80% of cases, a complete visualization of the SB was obtained with a reevaluation of the SB length. The median depth of maximal insertion was 85 cm (IQR 50–187). Conclusion: DBE is feasible, safe, and effective in SBS patients. Total enteroscopy can be frequently achieved with a single approach in these patients, allowing easy diagnostic and oncologic surveillance for SB and colonic malignancy.
  • The Near-Fatal Bath: A Case Report With Literature Review of Diagnosis and Management of Cannabinoid Hyperemesis Syndrome
    Nicola Siragusa, Andrea Costantino, Luisa Spina, Maurizio Vecchi
    Case Reports in Medicine, 2026
    Cannabinoid Hyperemesis Syndrome (CHS) is a severe condition associated with chronic cannabis use, characterized by cyclic vomiting, abdominal pain, and compulsive hot baths for symptom relief. We present the case of a 35‐year‐old male with at least a decade‐long history of cannabis use who presented with recurrent episodes of vomiting and dehydration. He experienced a potentially fatal episode of hypothermia and cardiac arrest after losing consciousness during a prolonged hot bath. Despite extensive diagnostic evaluations after many years, CHS was not identified until it was confirmed based on the Rome IV clinical criteria and elevated urinary cannabinoid levels (449 ng/mL). Management included rehydration, parenteral nutrition, and capsaicin cream targeting the transient receptor potential vanilloid Type 1 (TRPV1), as traditional antiemetics were ineffective, in conjunction with cannabis cessation. This case highlights the need for early recognition of CHS to prevent severe complications and avoid unnecessary diagnostic investigations. Prolonged cannabis abstinence remains the only definitive treatment, requiring a multidisciplinary approach. Increased awareness among clinicians is essential for timely diagnosis and appropriate management.
  • The ballooned stomach: A hidden vascular threat
    Nicola Siragusa, Andrea Costantino, Luisa Spina, Maurizio Vecchi
    Digestive and Liver Disease, 2025
  • Assessment of nutritional status and eating behaviours in patients with chronic inflammatory bowel disease: a pilot study
    Alice Scricciolo, Vincenza Lombardo, Karla Amada Bascuñán, Magdalena Araya, Luca Elli, et al.
    European Journal of Clinical Nutrition, 2025
  • The Effectiveness of Yoga for Irritable Bowel Syndrome: A Systematic Review
    Francesco Pavan, Sunil Singh Yadav, Andrea Costantino, Alessandra Dell'Era, Monic Mastroianni, et al.
    Comprehensive Physiology, 2025
    Background Irritable Bowel Syndrome (IBS) is a common functional gastrointestinal disorder affecting 5%–10% of the global population and is characterized by recurrent abdominal pain and dysregulation of bowel movements. Many patients do not benefit from full remission of symptoms by conventional treatments. Recently, yoga has demonstrated its potential benefits in various medical conditions including IBS, as a result of its effect on the gut‐brain axis. This systematic review evaluates the effectiveness of yoga for the management of IBS. Methods We conducted a comprehensive literature search in PubMed and Scopus until March 2025 to identify studies on yogic posture, pranayama, and meditation in IBS. After excluding reviews, case reports, and studies not meeting age or design criteria, 10 studies were included. These were evaluated for methodological quality and classified as randomized controlled trials (RCTs) or non‐controlled trials. We analyzed outcomes related to gastrointestinal symptoms, quality of life, and psychological symptoms and examined the type of yoga administered. Results Yoga interventions led to amelioration of gastrointestinal symptoms, decreased anxiety and depression, and enhanced quality of life compared to usual care or wait‐list controls. Of note, the studies that fixed the change in the IBS Symptom Severity Scale scores as the primary outcome showed a moderate‐large effect of yoga on the improvement of symptoms compared to controls (Cohen's d range: 0.37–3.60). Conclusion These preliminary findings suggest that yoga could favorably influence both the physical and psychological aspects of IBS. However, high‐quality larger sample studies are needed to confirm the findings reported in the review.
  • The Role of Age at Onset on the Clinical Course and Biochemical Parameters of Anorexia Nervosa
    Lorenzo Ferrario, Andrea Costantino, Letizia Maria Affaticati, Massimo Clerici, Antonios Dakanalis, et al.
    Journal of Personalized Medicine, 2025
    Background: Anorexia nervosa (AN) has the highest mortality rate among psychiatric disorders, making early diagnosis and tailored management crucial. This study aimed to evaluate the impact of age at onset (AAO)—childhood/adolescence versus adulthood—on the clinical course and associated biochemical parameters. Methods: Seventy-six female patients with AN were divided into two groups based on AAO (<18 years vs. ≥18 years). Group comparisons were performed using t-tests for continuous variables and χ2 tests for categorical variables. Correlation analyses assessed associations between AAO and continuous variables. Significant findings were entered into regression models, including a binary logistic regression with AAO as the dependent variable and a linear regression with significant correlations as predictors. Results: The early-onset group showed significantly higher potassium levels and a lower sodium/potassium ratio (Na+/K+) compared with the late-onset group (potassium: t = 0.93, p < 0.01; Na+/K+: t = 3.39, p < 0.01). AAO was strongly inversely correlated with potassium levels (r = −0.75, p < 0.01) and positively correlated with cholesterol (r = 0.574, p < 0.01) and Na+/K+ (r = 0.78, p = 0.01). Binary logistic regression correctly classified 87% of cases, showing that lower Na+/K+ was associated with earlier onset (OR = 2.23, p = 0.03). Linear regression confirmed significant associations of AAO with cholesterol levels (B = 0.07, p = 0.02) and Na+/K+ (B = 1.68, p < 0.01). Conclusions: AAO in AN is strongly associated with specific biochemical parameters. Early-onset patients exhibit more severe electrolyte imbalances, while late-onset cases show higher cholesterol levels, suggesting increased cardiovascular risk. These findings emphasize the importance of personalized treatment approaches according to AAO, although further studies are warranted to confirm these results.
  • Dramatic endoscopic presentation of Ileal HHV-6 enteritis in a patient treated for graft-versus-host disease
    Fabrizio Santagata, Andrea Costantino, Fabio Serpenti, Gian Eugenio Tontini
    Digestive and Liver Disease, 2025
  • The Ten Dietary Commandments for Patients with Irritable Bowel Syndrome: A Narrative Review with Pragmatic Indications
    Nicola Siragusa, Gloria Baldassari, Lorenzo Ferrario, Laura Passera, Beatrice Rota, et al.
    Nutrients, 2025
    Irritable bowel syndrome (IBS) is a gut–brain axis chronic disorder, characterized by recurrent abdominal pain and altered bowel habits in the absence of organic pathology. Nutrition plays a central role in symptom management, yet no single dietary strategy has demonstrated universal effectiveness. This narrative review critically evaluates current nutritional approaches to IBS. The low-Fermentable Oligo-, Di-, Mono-saccharides and Polyols (FODMAP) diet is the most extensively studied and provides short-term symptom relief, but its long-term effects on microbiota diversity remain concerning. The Mediterranean diet, due to its anti-inflammatory and prebiotic properties, offers a sustainable, microbiota-friendly option; however, it has specific limitations in the context of IBS, particularly due to the adverse effects of certain FODMAP-rich foods. A gluten-free diet may benefit individuals with suspected non-celiac gluten sensitivity, although improvements are often attributed to fructan restriction and placebo and nocebo effects. Lactose-free diets are effective in patients with documented lactose intolerance, while a high-soluble-fiber diet is beneficial for constipation-predominant IBS. IgG-based elimination diets are emerging but remain controversial and require further validation. In this review, we present the 10 dietary commandments for IBS, pragmatic and easily retained recommendations. It advocates a personalized, flexible, and multidisciplinary management approach, avoiding rigidity and standardized protocols, with the aim of optimizing adherence, symptom mitigation, and health-related quality of life. Future research should aim to evaluate, in real-world clinical settings, the impact and applicability of the 10 dietary commandments for IBS in terms of symptom improvement and quality of life
  • High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors
    Nunzio Zignani, Andrea Costantino, Michele Sagasta, Clara Dibenedetto, Riccardo Perbellini, et al.
    Vaccines, 2025
    Background: The COVID-19 pandemic highlighted the vulnerability of immunocompromised individuals, including liver transplant recipients (LTRs), who often exhibit reduced vaccine immunogenicity. While initial vaccine doses and subsequent boosters improved immune response, LTRs were prioritized for vaccination. Studies have shown increased antibody response after each booster dose. Vaccine hesitancy, defined as delayed or refused vaccination despite availability, poses a public health challenge, often fueled by misinformation. This study aimed to evaluate anti-spike antibody responses in vaccinated LTRs after two initial doses and at least one booster, also assessing adherence to subsequent doses. Methods: We conducted a retrospective observational study at a transplant center in Milan, Italy, between January 2021 and December 2023. LTRs who had received four or more doses of mRNA vaccines (Pfizer or Moderna) were included. Anti-spike antibody levels were measured 60–80 days after each dose. Data on vaccination status were collected in January 2024. Statistical analysis was performed to compare antibody responses and identify predictive factors. Results: LTRs showed a significant increase in anti-spike antibody responses after the first booster compared to the second dose with a trend versus a further increase following the fourth dose in a subgroup of the patients receiving two booster doses. However, adherence to booster doses decreased over time. In LTRs, predictors of a weaker response after the second dose were chronic kidney disease and metabolic etiology at transplant. Conclusions: The study highlighted that in LTRs, multiple doses of the COVID-19 vaccine led to a continuous increase in anti-spike antibody responses. The progressive decline in adherence of LTRs “to further booster doses” should be related to the fact that after the spread of vaccination programs worldwide, COVID-19 is still a current infection, but it is much less severe than before.
  • Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey
    Fabio Cortellini, Anna Fichera, Alessia Dalila Guarino, Lucrezia Laterza, Luigina Vanessa Alemanni, et al.
    Journal of Clinical Medicine, 2025
  • Is IBS a Food Allergy? Confocal Laser Endomicroscopy Findings in Patients with IBS: A Narrative Review
    Francesco Pavan, Andrea Costantino, Gian Eugenio Tontini, Luca Elli, Nicola Siragusa, et al.
    Applied Sciences Switzerland, 2025
  • Microbiota-gut-brain axis: towards a microbiota-centred approach for irritable bowel syndrome
    Andrea Costantino, Gennaro Tagliamonte, Marcello Romeo
    Journal of Biological Research Italy, 2025
  • The Epidemiology and Clinical Management of Short Bowel Syndrome and Chronic Intestinal Failure in Crohn’s Disease in Italy: An IG-IBD Survey
    Tommaso Pessarelli, Matilde Topa, Andrea Sorge, Nicoletta Nandi, Daniela Pugliese, et al.
    Nutrients, 2024
  • Functional Abdominal Bloating and Gut Microbiota: An Update
    Salvatore Crucillà, Federico Caldart, Marco Michelon, Giovanni Marasco, Andrea Costantino
    Microorganisms, 2024
  • Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis
    Andrea Costantino, Alessandra Piagnani, Riccardo Caccia, Andrea Sorge, Marco Maggioni, et al.
    Digestive and Liver Disease, 2024
  • Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicentre prospective cohort study
    Nicole Piazza O Sed, Daniele Noviello, Elisabetta Filippi, Francesco Conforti, Federica Furfaro, et al.
    Journal of Crohn S and Colitis, 2024
  • Human cytomegalovirus-related gastrointestinal disease after kidney transplantation: A systematic review
    Ilaria Elena Zais, Alessandro Sirotti, Samuele Iesari, Edoardo Campioli, Andrea Costantino, et al.
    Clinical Transplantation, 2024
  • Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
    Andrea Costantino, Marco Michelon, Daniele Noviello, Fabio Salvatore Macaluso, Salvo Leone, et al.
    Vaccines, 2023
  • Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences?
    Elia Fracas, Andrea Costantino, Maurizio Vecchi, Massimiliano Buoli
    International Journal of Environmental Research and Public Health, 2023
  • Evaluation of a Single Determination of Gluten Immunogenic Peptides in Urine from Unaware Celiac Patients to Monitor Gluten-Free Diet Adherence
    Vincenza Lombardo, Alice Scricciolo, Andrea Costantino, Luca Elli, Giorgia Legnani, et al.
    Nutrients, 2023
  • Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade
    Luca Elli, Pietro Soru, Leda Roncoroni, Francesca Gaia Rossi, Valeria Ferla, et al.
    Digestive and Liver Disease, 2023
  • Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease
    Torsten Kucharzik, Rune Wilkens, Maria-Antonietta D’Agostino, Giovanni Maconi, Manuela Le Bars, et al.
    Clinical Gastroenterology and Hepatology, 2023
  • Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
    Elisabetta Degasperi, Maria Paola Anolli, Sara Colonia Uceda Renteria, Dana Sambarino, Marta Borghi, et al.
    Journal of Hepatology, 2022
  • The low-FODMAP diet and the gluten-free diet in the management of functional abdominal bloating and distension
    Tommaso Pessarelli, Andrea Sorge, Luca Elli, Andrea Costantino
    Frontiers in Nutrition, 2022

RECENT SCHOLAR PUBLICATIONS

  • BCNMD26-343: PROMOTION AND MONITORING OF PHYSICAL ACTIVITY WITH A DIGITAL APP IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: CLINICAL OUTCOMES AND FECAL MICROBIOTA ANALYSIS OF A …
    A Costantino, A Cremonesi, F Strati, T Pessarelli, C Ciafardini, C Amoroso, ...
    Digestive and Liver Disease 58, S17-S18 , 2026
    2026
  • ACNMD26-606: RETROSPECTIVE OBSERVATIONAL STUDY ON THE ENVIRONMENTAL SUSTAINABILITY AND MEDITERRANEAN DIET ADHERENCE IN COELIAC PATIENTS
    A Scricciolo, B Rota, V Lombardo, L Elli, G Paieri, A Costantino, ...
    Digestive and Liver Disease 58, S130-S131 , 2026
    2026
  • ACNMD26-569: GUT MICROBIOTA SIGNATURES DIFFERENTIATE PATIENTS WITH CONSTIPATION-PREDOMINANT AND DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    A Costantino, F Strati, A Cremonesi, N Siragusa, C Ciafardini, C Amoroso, ...
    Digestive and Liver Disease 58, S129-S130 , 2026
    2026
  • ACNMD26-175: IS IBS A FOOD ALLERGY? CONFOCAL LASER ENDOMICROSCOPY FINDINGS IN PATIENTS WITH IBS: A NARRATIVE REVIEW
    F Pavan, A Costantino, GE Tontini, L Elli, N Siragusa, G Lasagni, ...
    Digestive and Liver Disease 58, S80-S81 , 2026
    2026
  • ACNMD26-185: THE TEN DIETARY COMMANDMENTS FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME: AN EXPERT OPINION ON DIETARY STRATEGIES WITH CLEAR AND PRACTICAL RECOMMENDATIONS FOR IBS …
    N Siragusa, A Costantino, G Baldassari, L Ferrario, F Pavan, D Consalvo, ...
    Digestive and Liver Disease 58, S38 , 2026
    2026
  • Double-balloon enteroscopy evaluation and surveillance in patients with short bowel syndrome
    L Scaramella, A Sorge, GE Tontini, E Fracas, V Smania, A Costantino, ...
    Therapeutic Advances in Gastroenterology 19, 17562848251346272 , 2026
    2026
  • Oral Immunotherapy-Induced Changes in IgE, IgG, and IgA: A Review of Antibody Isotype Shifts and Their Clinical Relevance in Food Allergy
    G Lasagni, L Vetrugno, CM Maggiore, C Galassetti, GD Colo, F Pavan, ...
    Antibodies 15 (1), 6 , 2026
    2026
  • The Near‐Fatal Bath: A Case Report With Literature Review of Diagnosis and Management of Cannabinoid Hyperemesis Syndrome
    N Siragusa, A Costantino, L Spina, M Vecchi
    Case Reports in Medicine 2026 (1), 5923650 , 2026
    2026
  • The ballooned stomach: A hidden vascular threat
    N Siragusa, A Costantino, L Spina, M Vecchi
    Digestive and liver disease: official journal of the Italian Society of … , 2025
    2025
  • Assessment of nutritional status and eating behaviours in patients with chronic inflammatory bowel disease: a pilot study
    A Scricciolo, V Lombardo, KA Bascuñán, M Araya, L Elli, A Costantino, ...
    European Journal of Clinical Nutrition 79 (11), 1130-1137 , 2025
    2025
  • The effectiveness of yoga for irritable bowel syndrome: a systematic review
    F Pavan, SS Yadav, A Costantino, A Dell'Era, M Mastroianni, M Buoli
    Comprehensive Physiology 15 (5), e70061 , 2025
    2025
    Citations: 5
  • Ultrasound Measurement of Psoas Muscle Compared to Bioelectrical Impedance Analysis for the Evaluation of Skeletal Muscle Mass in Patients with Inflammatory Bowel Disease: a …
    MF Anna Fichera, Andrea Costantino, Caterina Biagia Pelligra, Fabrizio ...
    United European Gastroenterology Week 2025 13 (S8), 548 , 2025
    2025
  • Evaluation of adherence to the gluten-free diet in celiac patients: the innovative detection of gluten immunogenic peptides (GIPS) compared to traditional methods
    V Lombardo, A Scricciolo, L Roncoroni, L Scaramella, A Costantino, ...
    Clinical Nutrition ESPEN 69, 998 , 2025
    2025
  • Assessment of wheat, gluten, and fructan intake in the diet of adult patients with chronic inflammatory bowel diseases
    A Scricciolo, KA Bascuñán, V Lombardo, L Elli, F Caprioli, GE Tontini, ...
    Clinical Nutrition ESPEN 69, 998 , 2025
    2025
  • Dramatic endoscopic presentation of Ileal HHV-6 enteritis in a patient treated for graft-versus-host disease
    F Santagata, A Costantino, F Serpenti, GE Tontini
    Digestive and liver disease: official journal of the Italian Society of … , 2025
    2025
  • The ten dietary commandments for patients with irritable bowel syndrome: a narrative review with pragmatic indications
    N Siragusa, G Baldassari, L Ferrario, L Passera, B Rota, F Pavan, ...
    Nutrients 17 (15), 2496 , 2025
    2025
    Citations: 7
  • Promotion and Monitoring of Physical Activity with a Digital App in Patients with Irritable Bowel Syndrome: Clinical Outcomes and Fecal Microbiota Analysis af a Randomized …
    A Costantino
    Università degli Studi di Milano , 2025
    2025
  • La formazione ecografica tra i giovani Gastroenterologi italiani: i risultati della survey AGGEI
    A Costantino
    iGUT 2, 11-14 , 2025
    2025
  • Sa1091: URINARY AND FECAL GLUTEN IMMUNOGENIC PEPTIDES’DETECTION TO SUPPORT GLUTEN CHALLENGE TEST
    A Scricciolo, V Lombardo, L Roncoroni, K Bascuñan, M Vecchi, ...
    Gastroenterology 169 (1), S-349 , 2025
    2025
  • Microbiota-gut-brain axis: towards a microbiota-centred approach for irritable bowel syndrome
    A Costantino, G Tagliamonte, M Romeo
    Journal of Biological Research 98 (2) , 2025
    2025
    Citations: 2

MOST CITED SCHOLAR PUBLICATIONS

  • Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study
    F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ...
    Hepatology 63 (3), 827-838 , 2016
    2016
    Citations: 705
  • Development and validation of a new prognostic system for patients with hepatocellular carcinoma
    F Farinati, A Vitale, G Spolverato, TM Pawlik, T Huo, YH Lee, AC Frigo, ...
    PLoS medicine 13 (4), e1002006 , 2016
    2016
    Citations: 156
  • SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
    COVIDSurg Collaborative, GlobalSurg Collaborative
    British Journal of Surgery 108 (9), 1056-1063 , 2021
    2021
    Citations: 148
  • Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation
    M Allocca, E Filippi, A Costantino, S Bonovas, G Fiorino, F Furfaro, ...
    UEG Journal 9 (4), 438-442 , 2021
    2021
    Citations: 130
  • Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn’s disease
    T Kucharzik, R Wilkens, MA D’agostino, G Maconi, M Le Bars, M Lahaye, ...
    Clinical Gastroenterology and Hepatology 21 (1), 153-163. e12 , 2023
    2023
    Citations: 126
  • Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
    S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ...
    Alimentary pharmacology & therapeutics 45 (1), 160-168 , 2017
    2017
    Citations: 99
  • A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma
    G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ...
    Liver International 37 (8), 1157-1166 , 2017
    2017
    Citations: 95
  • The evolutionary scenario of hepatocellular carcinoma in Italy: an update
    L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ...
    Liver International 37 (2), 259-270 , 2017
    2017
    Citations: 94
  • Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome
    L Bucci, F Garuti, V Camelli, B Lenzi, F Farinati, EG Giannini, F Ciccarese, ...
    Alimentary pharmacology & therapeutics 43 (3), 385-399 , 2016
    2016
    Citations: 87
  • Nutrition in patients with inflammatory bowel diseases: a narrative review
    L Roncoroni, R Gori, L Elli, GE Tontini, L Doneda, L Norsa, M Cuomo, ...
    Nutrients 14 (4), 751 , 2022
    2022
    Citations: 86
  • The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: a multicenter cohort study
    A Vitale, F Farinati, TM Pawlik, AC Frigo, EG Giannini, L Napoli, ...
    Liver International 39 (8), 1478-1489 , 2019
    2019
    Citations: 84
  • Functional gastrointestinal and somatoform symptoms five months after SARS‐CoV‐2 infection: a controlled cohort study
    D Noviello, A Costantino, A Muscatello, A Bandera, D Consonni, M Vecchi, ...
    Neurogastroenterology & Motility 34 (2), e14187 , 2022
    2022
    Citations: 82
  • Application of the intermediate-stage subclassification to patients with untreated hepatocellular carcinoma
    EG Giannini, A Moscatelli, G Pellegatta, A Vitale, F Farinati, F Ciccarese, ...
    Official journal of the American College of Gastroenterology| ACG 111 (1), 70-77 , 2016
    2016
    Citations: 80
  • Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
    E Degasperi, MP Anolli, SCU Renteria, D Sambarino, M Borghi, ...
    Journal of Hepatology 77 (6), 1525-1531 , 2022
    2022
    Citations: 79
  • SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
    COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ...
    Anaesthesia 77 (1), 28-39 , 2022
    2022
    Citations: 74
  • SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
    GS Collaborative, COVIDSurg Collaborative
    The British journal of surgery 108 (9), 1056 , 2021
    2021
    Citations: 71
  • Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
    A Pecorelli, B Lenzi, A Gramenzi, F Garuti, F Farinati, EG Giannini, ...
    Liver International 37 (3), 423-433 , 2017
    2017
    Citations: 62
  • Utility of tumor burden score to stratify prognosis of patients with hepatocellular cancer: results of 4759 cases from ITA. LI. CA study group
    A Vitale, Q Lai, F Farinati, L Bucci, EG Giannini, L Napoli, F Ciccarese, ...
    Journal of Gastrointestinal Surgery 22 (5), 859-871 , 2018
    2018
    Citations: 60
  • Recurrence of hepatocellular carcinoma after liver transplantation: an update
    A Mazzola, A Costantino, S Petta, TV Bartolotta, M Raineri, R Sacco, ...
    Future Oncology 11 (21), 2923-2936 , 2015
    2015
    Citations: 60
  • Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
    British Journal of Surgery 110 (7), 804-817 , 2023
    2023
    Citations: 48

GRANT DETAILS

In 2020: Starting Gran "Bando della ricerca finalizzata anno 2019" Ministero della Salute
Principal Investigator of the project entitled "Oxidative stress biomarkers as clinical indicators in complicated celiac disease", Valide Score 7.5 (eight classified out 256 projects).


In 2019: awarded travel grant from the United European Gastroenterology for the abstract "Diagnostic accuracy
of a pocket-size ultrasound device in indentifying liver surface nodularity for fibrosis staging in chronic liver diseases".

In 2019: 1st classified at the concourse for PhD in Clinical Research at the University of Milan; titled High-throughput
mutation screening of pure T-cell subpopulations as a guide to personalized medicine in celiac patients with a refractory
disease. Total score of 86 points.